Drug Discovery Market Overview
Real-time insights with the help of drug discovery is a key factor driving the global drug discovery market, says Fortune Business Insights in a report, titled “Drug Discovery Informatics Market Size, Share & Industry Analysis, By Service Type (In-house, Outsourced), By Modality (Cloud-based Systems, In-campus Platform), By Application (Data Sequencing, Molecular Docking, Identification and Validation Informatics, Target Data Analysis, Others), By End User (Pharmaceutical Companies, Contract Research Organizations, Biotechnology Companies, Others) and Regional Forecast, 2019-2026.”
The rising shift of healthcare organizations towards data-driven technologies is expected to aid growth of the global drug discovery informatics market
Browse Complete Report:
List of Major Companies Covered in The Global Drug Discovery Market Are:
- PerkinElmer Inc.
- Charles River
- Infosys Limited
- International Business Machines Corporation (IBM)
- Amazon Web Services
- Schrödinger LLC.
- Boehringer Ingelheim International GmbH
- CORE INFORMATICS
- Informatics Matters Ltd.
- Tata Consultancy Services Limited
As per the report, the increasing advancements in the drug discovery informatics by key players to maintain scientific research workflows and to offer an efficient platform to access desirable data is expected to boost the drug discovery informatics market revenue during the forecast period. For instance, Accenture, one of the giants in the software industry, in collaboration with Amazon Web Services (AWS) and Merck & Co., Inc., announced the launch of new cloud-based drug discovery informatics platform to improve productivity and efficiency in drug discovery in the pharmaceutical industry.
The report sheds light on the latest advancements and developments in the global drug discovery informatics market. The report offers key insights and shares relevant statistics to help companies expand their business and benefit perpetually.
Launch Of Version 10 Of D360m By Certara® Will Enable Growth
Certara®, the global leader in model-informed drug development and regulatory science, announced the launch of version 10 of D360™, a data informatics platform for discovery scientists. D360 self-service data access, integration and visualization solution will be used for query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions. The launch of D360™ is expected to accelerate the growth of the global drug discovery informatics market owing to its technology which enables researchers to cut dramatically the time required to access and analyze data and gain new insights.
Get Sample PDF:
Furthermore, the rising shift from conventional methods to data-driven technologies by pharmaceutical companies is expected to enable the growth of the global drug discovery informatics market. In addition, benefits provided by drug delivery informatics solutions such as data organization, improved recording & retrieval of the drug discovery process and real-time insights, which helps in the decision-making process. This factor is expected to fuel demand for drug discovery informatics, which, in, turn will propel growth of the global drug discovery informatics market.
Rising Emphasis On Data-Driven Solutions Will Boost Growth In North America
Geographically, the global drug discovery informatics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the drug discovery informatics market in 2018 and is expected to remain dominant during the forecast period owing to the rising emphasis by pharmaceutical and biotechnology companies for the utilization of data-driven solutions. Furthermore, the presence of key players in the region will also enable growth in North America.
Europe and the Asia Pacific are expected to grow at a significant rate during the forecast period owing to the increasing demand for advanced solutions with data visualization, data analytics, integrated workflows and better user interface. The Middle East & Africa is expected to register on a considerable rate in the global drug discovery informatics market owing to comparatively lower research and development expenditure. In addition, lack of infrastructure in the Middle East & Africa will further restrict the growth of the drug discovery informatics market in the region.
Speak to analyst:
Secondary Research is conducted to derive the following information:
- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.
- Details in relation to the parent market/related market, value and supply chain analysis, distribution channels, trade analysis, and recent technological developments.
- Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities.
- Market & technological trends and new product developments
More Trending Topics from Fortune Business Insights:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245